VolitionRx Limited Long-Term Debt, Maturity, Year Four and Five
VolitionRx Limited (VNRX) had Long-Term Debt, Maturity, Year Four and Five of $674.83 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturingInYearsFourAndFive · last filed 2026-08-13
- 2026-06-30: Long-Term Debt, Maturity, Year Four and Five $674.83K.
- 2026-03-31: Long-Term Debt, Maturity, Year Four and Five $680.71K.
- 2025-12-31: Long-Term Debt, Maturity, Year Four and Five $55.57K.
- 2025-09-30: Long-Term Debt, Maturity, Year Four and Five $199.86K.
| Period end | Long-Term Debt, Maturity, Year Four and Five |
|---|---|
| 2026-06-30 | $674.83K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $680.71K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $55.57K 10-K · filed 2026-03-31 |
| 2025-09-30 | $199.86K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $200.50K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $184.32K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $176.31K 10-K · filed 2025-03-31 |
| 2024-09-30 | $326.85K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $314.02K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $317.11K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $323.80K 10-K · filed 2024-03-25 |
| 2022-12-31 | $446.80K 10-K · filed 2023-03-15 |
| 2021-12-31 | $613.53K 10-K · filed 2022-03-30 |
| 2021-09-30 | $766.72K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $784.90K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $777.75K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $729.81K 10-K · filed 2021-03-22 |
| 2020-09-30 | $181.74K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $180.38K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $170.88K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $174.04K 10-K · filed 2020-02-20 |
| 2019-09-30 | $360.51K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $375.82K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $198.79K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $202.95K 10-K · filed 2019-03-13 |
| 2018-09-30 | $323.20K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $325.43K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $343.13K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |